These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 7677443)
1. In vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitor. Karran EH; Young TJ; Markwell RE; Harper GP Ann Rheum Dis; 1995 Aug; 54(8):662-9. PubMed ID: 7677443 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [TBL] [Abstract][Full Text] [Related]
3. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762 [TBL] [Abstract][Full Text] [Related]
4. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants. Todhunter RJ; Fubini SL; Wootton JA; Lust G J Rheumatol; 1996 Jul; 23(7):1207-13. PubMed ID: 8823694 [TBL] [Abstract][Full Text] [Related]
5. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Kozaci LD; Buttle DJ; Hollander AP Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612 [TBL] [Abstract][Full Text] [Related]
6. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteases are involved in granuloma-induced cartilage degradation. Trancart MM; Chalmeigne N; Girardot C; Zarpanelian C; Prigent D Int J Tissue React; 1991; 13(4):165-9. PubMed ID: 1821411 [TBL] [Abstract][Full Text] [Related]
8. Myofibroblast accumulation correlates with the formation of fibrotic tissue in a rat air pouch model. Bjärdahlen A; Onnervik PO; Westergren-Thorsson G; Malmström A; Särnstrand B J Rheumatol; 2002 Aug; 29(8):1698-707. PubMed ID: 12180733 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants. Sah RL; Chen AC; Grodzinsky AJ; Trippel SB Arch Biochem Biophys; 1994 Jan; 308(1):137-47. PubMed ID: 8311446 [TBL] [Abstract][Full Text] [Related]
10. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Andrews HJ; Plumpton TA; Harper GP; Cawston TE Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176 [TBL] [Abstract][Full Text] [Related]
14. The proteoglycan metabolism, morphology and viability of articular cartilage treated with a synthetic matrix metalloproteinase inhibitor. Steinmeyer J; Daufeldt S; Kalbhen DA Res Exp Med (Berl); 1997; 197(2):63-79. PubMed ID: 9380952 [TBL] [Abstract][Full Text] [Related]
15. Breakdown of proteoglycan and collagen induced in pig articular cartilage in organ culture. Dingle JT; Horsfield P; Fell HB; Barratt ME Ann Rheum Dis; 1975 Aug; 34(4):303-11. PubMed ID: 127555 [TBL] [Abstract][Full Text] [Related]
16. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage. Ratcliffe A; Azzo W; Saed-Nejad F; Lane N; Rosenwasser MP; Mow VC J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029 [TBL] [Abstract][Full Text] [Related]
17. Effect of Betula platyphylla var. japonica on proteoglycan release, type II collagen degradation, and matrix metalloproteinase expression in rabbit articular cartilage explants. Cho YJ; Huh JE; Kim DY; Kim NJ; Lee JD; Baek YH; Cho EM; Yang HR; Choi DY; Park DS Biol Pharm Bull; 2006 Jul; 29(7):1408-13. PubMed ID: 16819179 [TBL] [Abstract][Full Text] [Related]
18. [Role of aggrecanase and MMP in cartilage degradation]. Ishiguro N; Kojima T Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074 [TBL] [Abstract][Full Text] [Related]
19. Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Mort JS; Dodge GR; Roughley PJ; Liu J; Finch SJ; DiPasquale G; Poole AR Matrix; 1993 Mar; 13(2):95-102. PubMed ID: 8492744 [TBL] [Abstract][Full Text] [Related]
20. Differences in submicroscopic structure of the extracellular matrix of canine femoral and tibial condylar articular cartilages as revealed by polarization microscopical analysis. Módis L; Botos A; Kiviranta I; Lukácskó L; Helminen HJ Acta Biol Hung; 1996; 47(1-4):341-53. PubMed ID: 9124004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]